首页 > 最新文献

Tanaffos最新文献

英文 中文
A Case of Pneumothorax Following Radiation Therapy for Small Cell Lung Cancer in a Patient with Scleroderma-ILD. 硬皮病- ild小细胞肺癌放疗后发生气胸1例。
Q3 Medicine Pub Date : 2024-04-01
Fatih Uzer, Aykut Cilli

Connective tissue diseases, particularly scleroderma, pose a heightened risk for the development of malignancies such as breast and lung cancer. Stereotactic Body Radiation Therapy (SBRT) has emerged as an effective treatment modality for various cancers, including lung and breast cancers, due to its curative potential, especially for localized extracranial tumors. A 69-year-old patient with a 30-pack-year smoking history presented with shortness of breath and bilateral diffuse rales on chest auscultation during the outpatient clinic visit. Notably, the patient had not received scleroderma treatment for a year at the time of radiation therapy. Despite the recognized sensitivity of the lungs to radiotherapy, the occurrence of pneumothorax and pneumomediastinum following SBRT in this case raises concerns about the potential complications in scleroderma-ILD patients with lung cancer. This report underscores the need for comprehensive risk assessment and careful consideration of alternative treatment strategies for lung cancer in scleroderma patients, particularly those with pre-existing lung involvement. Further research is warranted to elucidate the mechanisms and risk factors associated with complications following radiotherapy in this patient population, guiding clinicians in optimizing therapeutic approaches for improved outcomes.

结缔组织疾病,特别是硬皮病,增加了患乳腺癌和肺癌等恶性肿瘤的风险。立体定向全身放射治疗(SBRT)由于其治疗潜力,特别是局部颅外肿瘤,已成为包括肺癌和乳腺癌在内的各种癌症的有效治疗方式。患者69岁,吸烟史30包年,在门诊就诊时胸部听诊表现为呼吸急促,双侧弥漫性啰音。值得注意的是,患者在接受放射治疗时一年没有接受硬皮病治疗。尽管肺对放疗的敏感性是公认的,但该病例在SBRT后发生气胸和纵隔气引起了人们对硬皮病- ild肺癌患者潜在并发症的关注。该报告强调了对硬皮病患者,特别是已有肺部受累的患者,进行全面风险评估和仔细考虑肺癌替代治疗策略的必要性。需要进一步的研究来阐明与该患者放疗后并发症相关的机制和危险因素,指导临床医生优化治疗方法以改善结果。
{"title":"A Case of Pneumothorax Following Radiation Therapy for Small Cell Lung Cancer in a Patient with Scleroderma-ILD.","authors":"Fatih Uzer, Aykut Cilli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Connective tissue diseases, particularly scleroderma, pose a heightened risk for the development of malignancies such as breast and lung cancer. Stereotactic Body Radiation Therapy (SBRT) has emerged as an effective treatment modality for various cancers, including lung and breast cancers, due to its curative potential, especially for localized extracranial tumors. A 69-year-old patient with a 30-pack-year smoking history presented with shortness of breath and bilateral diffuse rales on chest auscultation during the outpatient clinic visit. Notably, the patient had not received scleroderma treatment for a year at the time of radiation therapy. Despite the recognized sensitivity of the lungs to radiotherapy, the occurrence of pneumothorax and pneumomediastinum following SBRT in this case raises concerns about the potential complications in scleroderma-ILD patients with lung cancer. This report underscores the need for comprehensive risk assessment and careful consideration of alternative treatment strategies for lung cancer in scleroderma patients, particularly those with pre-existing lung involvement. Further research is warranted to elucidate the mechanisms and risk factors associated with complications following radiotherapy in this patient population, guiding clinicians in optimizing therapeutic approaches for improved outcomes.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 4","pages":"413-416"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464833/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Cognitive Behavioral Therapy and Motivational Interviewing on Perceived Stress and ICU Stay in Neurosurgical Patients: A Quasi-Experimental Study. 认知行为疗法和动机性访谈对神经外科患者感知压力和ICU住院时间的影响:一项准实验研究。
Q3 Medicine Pub Date : 2024-04-01
Ali Solgi, Alireza Zali, Hassan Ahadi, Farhad Jomehri

Background: Neurosurgical operations, especially for brain tumors, are among the most stressful medical procedures due to diagnostic uncertainties, high morbidity, and long post-operative recovery, including ICU admission. Stress management interventions may improve outcomes. This study aimed to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI) in reducing perceived pre- and post-operative stress and ICU stay in patients undergoing brain surgery.

Materials and methods: In a quasi-experimental design, 80 neurosurgical candidates admitted to Shohadaye Tajrish Hospital during 2020-2022 were randomly assigned to intervention and control groups. The intervention group received 15 CBT-based sessions focused on stress management and cognitive restructuring. Stress levels were assessed using Cohen's Perceived Stress Scale (1983), and CBT protocols followed Miller (2003). Data were analyzed with SPSS using chi-square tests, independent and paired t-tests, and ANCOVA.

Results: Patients who received CBT demonstrated significantly lower perceived stress scores postoperatively (p<0.001) and had a shorter ICU stay by an average of 3.2 days (p=0.049). No significant demographic differences were observed between groups.

Conclusion: CBT significantly reduces perioperative stress and ICU duration in neurosurgical patients. Integrating psychological interventions like CBT into preoperative care protocols may enhance recovery, reduce complications, and lower healthcare costs.

背景:神经外科手术,特别是脑肿瘤手术,由于诊断的不确定性、高发病率和术后长期恢复(包括ICU住院),是压力最大的医疗程序之一。压力管理干预可以改善结果。本研究旨在比较认知行为疗法(CBT)和动机访谈(MI)在减少颅脑手术患者术前和术后应激和ICU住院时间方面的效果。材料与方法:采用准实验设计,将2020-2022年在Shohadaye Tajrish医院住院的80名神经外科候选人随机分为干预组和对照组。干预组接受了15次基于cbt的会议,重点是压力管理和认知重组。压力水平的评估采用Cohen's Perceived Stress Scale (1983), CBT协议采用Miller(2003)。数据采用SPSS统计软件进行分析,采用卡方检验、独立t检验、配对t检验和方差分析。结果:接受CBT治疗的患者术后感知应激评分明显降低(p结论:CBT可显著降低神经外科患者围手术期应激和ICU时间。将CBT等心理干预纳入术前护理方案可能会促进康复,减少并发症,降低医疗成本。
{"title":"Effectiveness of Cognitive Behavioral Therapy and Motivational Interviewing on Perceived Stress and ICU Stay in Neurosurgical Patients: A Quasi-Experimental Study.","authors":"Ali Solgi, Alireza Zali, Hassan Ahadi, Farhad Jomehri","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Neurosurgical operations, especially for brain tumors, are among the most stressful medical procedures due to diagnostic uncertainties, high morbidity, and long post-operative recovery, including ICU admission. Stress management interventions may improve outcomes. This study aimed to compare the effectiveness of Cognitive Behavioral Therapy (CBT) and Motivational Interviewing (MI) in reducing perceived pre- and post-operative stress and ICU stay in patients undergoing brain surgery.</p><p><strong>Materials and methods: </strong>In a quasi-experimental design, 80 neurosurgical candidates admitted to Shohadaye Tajrish Hospital during 2020-2022 were randomly assigned to intervention and control groups. The intervention group received 15 CBT-based sessions focused on stress management and cognitive restructuring. Stress levels were assessed using Cohen's Perceived Stress Scale (1983), and CBT protocols followed Miller (2003). Data were analyzed with SPSS using chi-square tests, independent and paired t-tests, and ANCOVA.</p><p><strong>Results: </strong>Patients who received CBT demonstrated significantly lower perceived stress scores postoperatively (p<0.001) and had a shorter ICU stay by an average of 3.2 days (p=0.049). No significant demographic differences were observed between groups.</p><p><strong>Conclusion: </strong>CBT significantly reduces perioperative stress and ICU duration in neurosurgical patients. Integrating psychological interventions like CBT into preoperative care protocols may enhance recovery, reduce complications, and lower healthcare costs.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 4","pages":"403-408"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hodgkin's Lymphoma in a 34-Year-Old Patient with Digital Clubbing: A Case Report. 34岁霍奇金淋巴瘤伴数字球棍1例。
Q3 Medicine Pub Date : 2024-04-01
Pouyan Ebrahimi, Jalal Heshmatnia, Amirmorteza Solemanijoniani

Background: This is a rare condition, especially in adults, where digital clubbing presents as the initial manifestation of lymphoma. Here, we report a case of intrathoracic Hodgkin's disease (HD) with digital clubbing.

Case presentation: A 34-year-old female presented with B symptoms and a history of dyspnea. She did not take any particular medicine and had no history of any specific disease in herself or her family. In the examination, the patient has digital clubbing in the fingers and toes, which is painless. He also had decreased respiratory sounds and dullness in the right lung. After a CT scan and observation of consolidation and effusion, we performed a bronchoscopy on the patient. Finally, with the diagnosis of Hodgkin's lymphoma in the pathological reports, he was subjected to appropriate treatment measures.

Conclusion: A precise examination and paraclinical assistance are needed to rule out intrathoracic malignancies in patients with digital clubbing.

背景:这是一种罕见的情况,特别是在成人中,其中数字棍棒表现为淋巴瘤的初始表现。在此,我们报告一例胸椎内何杰金氏病(HD)伴数字棒状物。病例表现:34岁女性,有B型症状和呼吸困难史。她没有服用任何特定的药物,她本人或她的家庭没有任何特定的疾病史。在检查中,患者的手指和脚趾有指状刺,无痛。他也有呼吸音减少和右肺迟钝。在CT扫描和观察实变和积液后,我们对患者进行了支气管镜检查。最后,在病理报告中诊断为霍奇金淋巴瘤,并给予相应的治疗措施。结论:需要精确的检查和临床辅助来排除指棒症患者的胸内恶性肿瘤。
{"title":"Hodgkin's Lymphoma in a 34-Year-Old Patient with Digital Clubbing: A Case Report.","authors":"Pouyan Ebrahimi, Jalal Heshmatnia, Amirmorteza Solemanijoniani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>This is a rare condition, especially in adults, where digital clubbing presents as the initial manifestation of lymphoma. Here, we report a case of intrathoracic Hodgkin's disease (HD) with digital clubbing.</p><p><strong>Case presentation: </strong>A 34-year-old female presented with B symptoms and a history of dyspnea. She did not take any particular medicine and had no history of any specific disease in herself or her family. In the examination, the patient has digital clubbing in the fingers and toes, which is painless. He also had decreased respiratory sounds and dullness in the right lung. After a CT scan and observation of consolidation and effusion, we performed a bronchoscopy on the patient. Finally, with the diagnosis of Hodgkin's lymphoma in the pathological reports, he was subjected to appropriate treatment measures.</p><p><strong>Conclusion: </strong>A precise examination and paraclinical assistance are needed to rule out intrathoracic malignancies in patients with digital clubbing.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 4","pages":"417-420"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 15-Year-Old Girl with Chronic Cough and a History of Asthma Treatment. 15岁女孩慢性咳嗽,有哮喘治疗史。
Q3 Medicine Pub Date : 2024-04-01
Maryam Hassanzad, Korosh Fakhimi Derakhshan, Ali Akbar Velayati
{"title":"A 15-Year-Old Girl with Chronic Cough and a History of Asthma Treatment.","authors":"Maryam Hassanzad, Korosh Fakhimi Derakhshan, Ali Akbar Velayati","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 4","pages":"421-422"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Rate Variability in Obstructive Sleep Apnea: Association with Excessive Daytime Sleepiness and Cardiovascular Risk. 阻塞性睡眠呼吸暂停的心率变异性:与白天过度嗜睡和心血管风险相关。
Q3 Medicine Pub Date : 2024-04-01
Besharat Rahimi, Niloofar Khoshnam Rad, Tayebe Mohammad Alizade, Somaye Mohammadi, Shahram Firoozbakhsh

Background: Obstructive sleep apnea (OSA) is associated with increased vagal activity, sympathetic nervous system activation, and cardiovascular complications. Excessive daytime sleepiness (EDS) in OSA patients is a predictor of cardiovascular and all-cause mortality. Heart rate variability (HRV) can be used to assess cardiac autonomic modulation, which is affected by OSA. This study aimed to evaluate the relationship between HRV and daily sleepiness in OSA patients based on the excessive sleep scale (ESS) scores.

Materials and methods: The study included 70 patients with OSA, divided into two groups: those with EDS (ESS ≥ 11) and those without sleepiness (ESS < 11). Time and frequency domain parameters were evaluated. The results were compared and analyzed between the two groups.

Results: Patients with OSA and EDS had higher cardiovascular risk, as indicated by different HRV parameters (higher low-frequency parameter and higher time domain parameters), compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients.

Conclusion: OSA patients with EDS had higher cardiovascular risk, as indicated by different HRV parameters, compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients. Further studies are needed to better understand the relationship between HRV and daily sleepiness in patients with OSA.

背景:阻塞性睡眠呼吸暂停(OSA)与迷走神经活动增加、交感神经系统激活和心血管并发症有关。OSA患者白天过度嗜睡(EDS)是心血管和全因死亡率的预测因子。心率变异性(HRV)可用于评估受OSA影响的心脏自主调节。本研究旨在基于过度睡眠量表(ESS)评分评估OSA患者HRV与日常嗜睡的关系。材料与方法:将70例OSA患者分为EDS组(ESS≥11)和非嗜睡组(ESS < 11)。对时域和频域参数进行了评估。对两组结果进行比较分析。结果:与不嗜睡的OSA患者相比,OSA和EDS患者的HRV参数(低频参数和时域参数均较高)不同,其心血管风险更高。ODI和AHI与VLF呈显著正相关,EDS患者的LF和VLF明显升高。结论:不同HRV参数显示,OSA合并EDS患者的心血管风险高于非困倦OSA患者。ODI和AHI与VLF呈显著正相关,EDS患者的LF和VLF明显升高。需要进一步的研究来更好地了解心率变异与OSA患者日常嗜睡之间的关系。
{"title":"Heart Rate Variability in Obstructive Sleep Apnea: Association with Excessive Daytime Sleepiness and Cardiovascular Risk.","authors":"Besharat Rahimi, Niloofar Khoshnam Rad, Tayebe Mohammad Alizade, Somaye Mohammadi, Shahram Firoozbakhsh","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnea (OSA) is associated with increased vagal activity, sympathetic nervous system activation, and cardiovascular complications. Excessive daytime sleepiness (EDS) in OSA patients is a predictor of cardiovascular and all-cause mortality. Heart rate variability (HRV) can be used to assess cardiac autonomic modulation, which is affected by OSA. This study aimed to evaluate the relationship between HRV and daily sleepiness in OSA patients based on the excessive sleep scale (ESS) scores.</p><p><strong>Materials and methods: </strong>The study included 70 patients with OSA, divided into two groups: those with EDS (ESS ≥ 11) and those without sleepiness (ESS < 11). Time and frequency domain parameters were evaluated. The results were compared and analyzed between the two groups.</p><p><strong>Results: </strong>Patients with OSA and EDS had higher cardiovascular risk, as indicated by different HRV parameters (higher low-frequency parameter and higher time domain parameters), compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients.</p><p><strong>Conclusion: </strong>OSA patients with EDS had higher cardiovascular risk, as indicated by different HRV parameters, compared to non-sleepy OSA patients. A significant positive correlation was found between ODI and AHI with VLF, and significantly higher LF and VLF in EDS patients. Further studies are needed to better understand the relationship between HRV and daily sleepiness in patients with OSA.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 4","pages":"371-375"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12464837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiviral Effects of Sinamaz®: Potentials for COVID-19 Management. Sinamaz®的抗病毒作用:治疗COVID-19的潜力。
Q3 Medicine Pub Date : 2024-03-01
Mohsen Naseri, Babak Daneshfard, Mehrdad Ravanshad, Arezoo Nabizadeh, Farzaneh Ghaffari
{"title":"Antiviral Effects of Sinamaz®: Potentials for COVID-19 Management.","authors":"Mohsen Naseri, Babak Daneshfard, Mehrdad Ravanshad, Arezoo Nabizadeh, Farzaneh Ghaffari","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 3","pages":"217-219"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimation of Survival Probability of Patients with COVID-19 Based on Information of Patients. 基于患者信息的COVID-19患者生存概率估算
Q3 Medicine Pub Date : 2024-03-01
Mehdi Kazempour Dizaji, Mohammad Varahram, Ali Zare, Arda Kiani, Niloufar Alizadeh Kolahdozi, Atefe Abedini, Rahim Roozbahani, Payam Tabarsi

Background: In medical science, the probability of survival is a crucial index used to assess patient outcomes. This study aims to estimate the survival probability of patients diagnosed with COVID-19.

Materials and methods: In a historical cohort study, the Kaplan-Meier method was used to assess the survival probability of 4,372 COVID-19 patients treated at Dr. Masih Daneshvari Hospital in Tehran during the pandemic.

Results: The study results indicated that 199 patients (4.6%) died during the treatment, while 4,173 patients (95.4%) were censored. The daily survival probability estimation for COVID-19 patients revealed that the highest and lowest survival probabilities within 100 days from disease onset were 96% and 55%, respectively. Additionally, the survival probabilities on the 20th, 50th, 70th, and 90th days from the onset of disease and treatment were 92%, 70%, 63%, and 61%, respectively.

Conclusion: Estimating the survival probability of COVID-19 patients offers clinicians valuable insights into mortality rates and the effectiveness of common therapeutic strategies in treating the disease.

背景:在医学中,生存概率是评估患者预后的重要指标。本研究旨在估计COVID-19患者的生存率。材料和方法:在一项历史队列研究中,使用Kaplan-Meier方法评估了大流行期间在德黑兰Masih Daneshvari医生医院治疗的4372名COVID-19患者的生存率。结果:研究结果显示,199例患者(4.6%)在治疗过程中死亡,4173例患者(95.4%)被剔除。对新冠肺炎患者的每日生存率估计显示,发病后100天内的最高和最低生存率分别为96%和55%。此外,发病和治疗后第20、50、70和90天的生存率分别为92%、70%、63%和61%。结论:估算COVID-19患者的生存概率为临床医生了解死亡率和常用治疗策略在治疗疾病中的有效性提供了有价值的见解。
{"title":"Estimation of Survival Probability of Patients with COVID-19 Based on Information of Patients.","authors":"Mehdi Kazempour Dizaji, Mohammad Varahram, Ali Zare, Arda Kiani, Niloufar Alizadeh Kolahdozi, Atefe Abedini, Rahim Roozbahani, Payam Tabarsi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>In medical science, the probability of survival is a crucial index used to assess patient outcomes. This study aims to estimate the survival probability of patients diagnosed with COVID-19.</p><p><strong>Materials and methods: </strong>In a historical cohort study, the Kaplan-Meier method was used to assess the survival probability of 4,372 COVID-19 patients treated at Dr. Masih Daneshvari Hospital in Tehran during the pandemic.</p><p><strong>Results: </strong>The study results indicated that 199 patients (4.6%) died during the treatment, while 4,173 patients (95.4%) were censored. The daily survival probability estimation for COVID-19 patients revealed that the highest and lowest survival probabilities within 100 days from disease onset were 96% and 55%, respectively. Additionally, the survival probabilities on the 20th, 50th, 70th, and 90th days from the onset of disease and treatment were 92%, 70%, 63%, and 61%, respectively<b>.</b></p><p><strong>Conclusion: </strong>Estimating the survival probability of COVID-19 patients offers clinicians valuable insights into mortality rates and the effectiveness of common therapeutic strategies in treating the disease.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 3","pages":"300-303"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Severity of Chronic Obstructive Pulmonary Disease and Left Ventricular Diastolic Dysfunction. 慢性阻塞性肺疾病严重程度与左室舒张功能不全的关系
Q3 Medicine Pub Date : 2024-03-01
Somayeh Lookzadeh, Seyyed Reza Seyyedi, Hamidreza Jamaati, Fatemehalsadat Miraboutalebi, Mahsa Rekabi

Background: Chronic obstructive pulmonary disease (COPD) is an inflammatory systemic disorder that affects the respiratory tract airways and breathing. Left ventricular diastolic dysfunction (LVDD), which is the inability of the ventricle to fill to a normal end-diastolic volume, may be observed in patients with severe COPD. This study aimed to evaluate LVDD in patients with COPD.

Materials and methods: This cross-sectional study included 58 patients under 65 years of age with COPD as the case group. Moreover, 58 patients with normal spirometry and without pulmonary or cardiac disease were included as the control group. They referred to the cardiologist for echocardiography. Patients were tested for C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptides (NT -pro BNP). Data were analyzed with SPSS for descriptive reports of the relationship between variables.

Results: The results showed that LVDD was significantly higher in COPD patients (60%) than in the control group (12.2%). Also, there was no significant relationship between LVDD and BMI in COPD patients. Evaluation of CRP and PRO-BNP showed that the distribution of patients in different diastolic function classes is similar. It was observed that with increasing COPD severity, LVDD severity increased (p-value =0.101). There is a direct relationship between total lung capacity (TLC) and LVDD (P-value <0.0001). In COPD patients, there was a significant relationship between diastolic function and SPAP (P-value <0.0019).

Conclusion: In general, it should be noted that the prevalence of LVDD in patients with COPD is significantly higher than in other people.

背景:慢性阻塞性肺疾病(COPD)是一种影响呼吸道和呼吸的炎症性全身性疾病。左心室舒张功能不全(LVDD),即心室不能充盈到正常的舒张末期容积,可在严重COPD患者中观察到。本研究旨在评估慢性阻塞性肺病患者的LVDD。材料和方法:本横断面研究纳入58例65岁以下COPD患者作为病例组。另外,58例肺功能正常且无肺部或心脏疾病的患者作为对照组。他们请心脏病专家做超声心动图检查。检测患者c反应蛋白(CRP)和n端前b型利钠肽(NT -pro BNP)。用SPSS对数据进行分析,以获得变量间关系的描述性报告。结果:COPD患者LVDD(60%)明显高于对照组(12.2%)。此外,慢性阻塞性肺病患者的LVDD与BMI之间没有显著关系。CRP和PRO-BNP的评估显示,不同舒张功能分级患者的分布相似。观察到随着COPD严重程度的增加,LVDD严重程度增加(p值=0.101)。总肺容量(TLC)与LVDD (p值)之间存在直接关系。结论:总体而言,COPD患者LVDD患病率明显高于其他人群。
{"title":"Relationship between Severity of Chronic Obstructive Pulmonary Disease and Left Ventricular Diastolic Dysfunction.","authors":"Somayeh Lookzadeh, Seyyed Reza Seyyedi, Hamidreza Jamaati, Fatemehalsadat Miraboutalebi, Mahsa Rekabi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) is an inflammatory systemic disorder that affects the respiratory tract airways and breathing. Left ventricular diastolic dysfunction (LVDD), which is the inability of the ventricle to fill to a normal end-diastolic volume, may be observed in patients with severe COPD. This study aimed to evaluate LVDD in patients with COPD.</p><p><strong>Materials and methods: </strong>This cross-sectional study included 58 patients under 65 years of age with COPD as the case group. Moreover, 58 patients with normal spirometry and without pulmonary or cardiac disease were included as the control group. They referred to the cardiologist for echocardiography. Patients were tested for C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptides (NT -pro BNP). Data were analyzed with SPSS for descriptive reports of the relationship between variables.</p><p><strong>Results: </strong>The results showed that LVDD was significantly higher in COPD patients (60%) than in the control group (12.2%). Also, there was no significant relationship between LVDD and BMI in COPD patients. Evaluation of CRP and PRO-BNP showed that the distribution of patients in different diastolic function classes is similar. It was observed that with increasing COPD severity, LVDD severity increased (p-value =0.101). There is a direct relationship between total lung capacity (TLC) and LVDD (P-value <0.0001). In COPD patients, there was a significant relationship between diastolic function and SPAP (P-value <0.0019).</p><p><strong>Conclusion: </strong>In general, it should be noted that the prevalence of LVDD in patients with COPD is significantly higher than in other people.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 3","pages":"294-299"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and Validation of a Persian Version of the Severe Respiratory Insufficiency Questionnaire (SRI). 波斯语版严重呼吸功能不全问卷(SRI)的翻译与验证。
Q3 Medicine Pub Date : 2024-03-01
Shohreh Kolagari, Zahra Sabzi, Mahmoud Khandashpour, Wolfram Windisch, Leila Teymouri Yeganeh, Elyas Hosseinzadeh Younesi

Background: Using Health-related quality of life (HRQL) in chronic patients with severe respiratory insufficiency (SRI) requires a valid instrument. Hence, this study aimed to translate and validate the Persian version of the Severe Respiratory Insufficiency Questionnaire in chronic patients with severe respiratory insufficiency.

Materials and methods: In this methodological study, the original version of the HRQL questionnaire in chronic patients with SRI was translated based on the approach presented by Wild et al. Face validity, content validity such as content validity index (CVI) and content validity ratio (CVR), convergent, and discriminant validity were evaluated. Moreover, construct validity evaluation was conducted by exploratory and confirmatory factor analyses (EFA & CFA).Reliability was also evaluated by calculating Cronbach's alpha and test-retest intraclass correlation coefficient (ICC). SPSS-16 and AMOS-24 software were used for data analysis.

Results: The target group approved the face validity of the questionnaire and the content validity index was 0.94. In total, 500 chronic patients with severe respiratory insufficiency participated in the construct validity. Seven factors were extracted in exploratory factor analysis as respiratory complaints, physical functioning, social relationship, anxiety, attendant symptoms and sleep, social functioning, and psychological well-being. These factors explained 73.91% of the total variance of the concept of HRQL in chronic patients with SRI. All factors confirmed in confirmatory factor analysis based on model fit indices [Comparative Fit Index (CFI)=0.94, Goodness of fit index (GFI)=0.94, Minimum Discrepancy Function by Degrees of Freedom divided (CMIN/DF) =2.99, and Root Mean Square Error of Approximation (RMSEA)=0.01]. Convergent and discriminant validity were also confirmed. Moreover, Cronbach's alpha coefficients of 0.84 and intraclass correlation coefficient of 0.82-0.96 with 15-day intervals confirmed the internal consistency of the instrument.

Conclusion: According to the findings of the present study, the Persian version of the SRI questionnaire, with 7 subscales and 40 items, is a valid and reliable instrument to assess the HRQL in chronic patients with SRI.

背景:在慢性严重呼吸功能不全(SRI)患者中使用健康相关生活质量(HRQL)需要一种有效的仪器。因此,本研究旨在翻译并验证波斯语版严重呼吸功能不全问卷在慢性严重呼吸功能不全患者中的应用。材料和方法:在本方法学研究中,原始版本的慢性SRI患者HRQL问卷是根据Wild等人提出的方法进行翻译的。评估了面部效度、内容效度指数(CVI)和内容效度比(CVR)等内容效度、收敛效度和判别效度。采用探索性因子分析(EFA)和验证性因子分析(CFA)进行结构效度评价。信度也通过计算Cronbach’s alpha和重测类内相关系数(test-retest class intraccorrelation coefficient, ICC)来评估。采用SPSS-16和AMOS-24软件进行数据分析。结果:目标人群对问卷的面效度表示认可,内容效度指数为0.94。共有500名慢性严重呼吸功能不全患者参与construct validity。探索性因素分析提取了7个因素,分别是呼吸系统疾病、身体功能、社会关系、焦虑、伴随症状和睡眠、社会功能和心理健康。这些因素解释了慢性SRI患者HRQL概念总方差的73.91%。根据模型拟合指标[比较拟合指数(CFI)=0.94,拟合优度指数(GFI)=0.94,最小自由度差异函数(CMIN/DF) =2.99,近似均方根误差(RMSEA)=0.01],验证性因子分析确认所有因素。收敛效度和判别效度也得到了证实。此外,Cronbach's alpha系数为0.84,类内相关系数为0.82-0.96,间隔时间为15天,证实了仪器的内部一致性。结论:根据本研究结果,波斯语版SRI问卷包含7个分量表和40个条目,是评估慢性SRI患者HRQL的有效可靠工具。
{"title":"Translation and Validation of a Persian Version of the Severe Respiratory Insufficiency Questionnaire (SRI).","authors":"Shohreh Kolagari, Zahra Sabzi, Mahmoud Khandashpour, Wolfram Windisch, Leila Teymouri Yeganeh, Elyas Hosseinzadeh Younesi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Using Health-related quality of life (HRQL) in chronic patients with severe respiratory insufficiency (SRI) requires a valid instrument. Hence, this study aimed to translate and validate the Persian version of the Severe Respiratory Insufficiency Questionnaire in chronic patients with severe respiratory insufficiency.</p><p><strong>Materials and methods: </strong>In this methodological study, the original version of the HRQL questionnaire in chronic patients with SRI was translated based on the approach presented by Wild et al. Face validity, content validity such as content validity index (CVI) and content validity ratio (CVR), convergent, and discriminant validity were evaluated. Moreover, construct validity evaluation was conducted by exploratory and confirmatory factor analyses (EFA & CFA).Reliability was also evaluated by calculating Cronbach's alpha and test-retest intraclass correlation coefficient (ICC). SPSS-16 and AMOS-24 software were used for data analysis.</p><p><strong>Results: </strong>The target group approved the face validity of the questionnaire and the content validity index was 0.94. In total, 500 chronic patients with severe respiratory insufficiency participated in the construct validity. Seven factors were extracted in exploratory factor analysis as respiratory complaints, physical functioning, social relationship, anxiety, attendant symptoms and sleep, social functioning, and psychological well-being. These factors explained 73.91% of the total variance of the concept of HRQL in chronic patients with SRI. All factors confirmed in confirmatory factor analysis based on model fit indices [Comparative Fit Index (CFI)=0.94, Goodness of fit index (GFI)=0.94, Minimum Discrepancy Function by Degrees of Freedom divided (CMIN/DF) =2.99, and Root Mean Square Error of Approximation (RMSEA)=0.01]. Convergent and discriminant validity were also confirmed. Moreover, Cronbach's alpha coefficients of 0.84 and intraclass correlation coefficient of 0.82-0.96 with 15-day intervals confirmed the internal consistency of the instrument.</p><p><strong>Conclusion: </strong>According to the findings of the present study, the Persian version of the SRI questionnaire, with 7 subscales and 40 items, is a valid and reliable instrument to assess the HRQL in chronic patients with SRI.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 3","pages":"266-279"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Pharmacological Approach to COVID-19 in a Referral Hospital in Tehran During Two Years. 德黑兰一家转诊医院两年来COVID-19药理学方法的变化
Q3 Medicine Pub Date : 2024-03-01
Seyed Mehran Marashian, Mohsen Sadeghi, Somayeh Lookzadeh, Azadeh Moradkhani, Akram Qanavati, Zeinab Chaghervand, Sanaz Soleimani, Farnaz Hadipour, Maryam Shahmorad, Mahboobeh Mohammadi, Shirin Esmaeili, Latifeh Javadi, Hooman Sharifi, Esmaeil Idani, Hamidreza Jamaati, Alireza Eslaminejad

Background: The current study attempts to look at the trend of medication prescription among inpatients with COVID-19 by comparing two groups of them who were admitted into our hospital at separate times at around two-year intervals.

Materials and methods: Through a retrospective cross-sectional design, the current study enrolled hospitalized cases from two separate periods including winter 2019 and summer 2021 to compare some characteristics of COVID-19 in addition to sex and age distribution as well as the approach and management and their changes as the time passed.

Results: Remdesivir was raised to be the most commonly used medication for COVID-19 after one and a half years when approved by the FDA in this regard. Tocilizumab was prescribed for just less than 6% of earlier pandemics in winter 2019 while used in more than half of hospitalizations in 2021. After two years, corticosteroids are used in 98.6% of the cases at least in our center.

Conclusion: Exact medication administration to target COVID-19 and accurate vaccination in addition to "Herd immunity" among the global population seems to be the chief secret of the current success at least for partial control of the disease now.

背景:本研究试图通过比较两组分别在两年左右的时间入住我院的COVID-19住院患者的用药趋势。材料与方法:本研究通过回顾性横断面设计,纳入2019年冬季和2021年夏季两个不同时期的住院病例,比较COVID-19除性别和年龄分布外的一些特征,以及方法和管理及其随时间的变化。结果:Remdesivir在获得FDA批准的一年半后,成为COVID-19最常用的药物。2019年冬季,托珠单抗仅用于不到6%的早期流行病,而在2021年,超过一半的住院治疗中使用了托珠单抗。两年后,至少在我们中心98.6%的病例使用了皮质类固醇。结论:在全球人群中,除了“群体免疫”外,针对COVID-19的精确药物管理和准确的疫苗接种似乎是目前至少部分控制疾病成功的主要秘诀。
{"title":"Changes in Pharmacological Approach to COVID-19 in a Referral Hospital in Tehran During Two Years.","authors":"Seyed Mehran Marashian, Mohsen Sadeghi, Somayeh Lookzadeh, Azadeh Moradkhani, Akram Qanavati, Zeinab Chaghervand, Sanaz Soleimani, Farnaz Hadipour, Maryam Shahmorad, Mahboobeh Mohammadi, Shirin Esmaeili, Latifeh Javadi, Hooman Sharifi, Esmaeil Idani, Hamidreza Jamaati, Alireza Eslaminejad","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The current study attempts to look at the trend of medication prescription among inpatients with COVID-19 by comparing two groups of them who were admitted into our hospital at separate times at around two-year intervals.</p><p><strong>Materials and methods: </strong>Through a retrospective cross-sectional design, the current study enrolled hospitalized cases from two separate periods including winter 2019 and summer 2021 to compare some characteristics of COVID-19 in addition to sex and age distribution as well as the approach and management and their changes as the time passed.</p><p><strong>Results: </strong>Remdesivir was raised to be the most commonly used medication for COVID-19 after one and a half years when approved by the FDA in this regard. Tocilizumab was prescribed for just less than 6% of earlier pandemics in winter 2019 while used in more than half of hospitalizations in 2021. After two years, corticosteroids are used in 98.6% of the cases at least in our center.</p><p><strong>Conclusion: </strong>Exact medication administration to target COVID-19 and accurate vaccination in addition to \"Herd immunity\" among the global population seems to be the chief secret of the current success at least for partial control of the disease now.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 3","pages":"250-255"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tanaffos
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1